Cargando…
Understanding Drug Repurposing From the Perspective of Biomedical Entities and Their Evolution: Bibliographic Research Using Aspirin
BACKGROUND: Drug development is still a costly and time-consuming process with a low rate of success. Drug repurposing (DR) has attracted significant attention because of its significant advantages over traditional approaches in terms of development time, cost, and safety. Entitymetrics, defined as...
Autores principales: | Li, Xin, Rousseau, Justin F, Ding, Ying, Song, Min, Lu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327595/ https://www.ncbi.nlm.nih.gov/pubmed/32543442 http://dx.doi.org/10.2196/16739 |
Ejemplares similares
-
Bibliographic Entity Automatic Recognition and Disambiguation
por: Al-Natsheh, Hussein
Publicado: (2015) -
Anti-COVID drugs: repurposing existing drugs or search for new complex entities, strategies and perspectives
por: Pawełczyk, Anna, et al.
Publicado: (2020) -
Drug Repurposing: a Shortcut to New Biological Entities
por: Rao, Nutan, et al.
Publicado: (2022) -
Knowledge evolution in physics research: An analysis of bibliographic coupling networks
por: Liu, Wenyuan, et al.
Publicado: (2017) -
Aspirin at 120: Retiring, recombining, or repurposing?
por: Patrono, Carlo, et al.
Publicado: (2021)